MedTrace Logo

Evaluating Refractive and Visual Outcomes With the Alcon Toric ReSTOR +2.5 and +3.0 Models

NCT03856944 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2021-08-06

Study results available
· View outcomes & findings →

Summary

The study will evaluate visual acuity and visual function with a 'blended' ReSTOR Toric intraocular lens (IOL) implantation after cataract surgery.

Conditions

  • Cataract

Interventions

DEVICE

ReSTOR Toric

ReSTOR Toric bilateral IOL implantation

Sponsors & Collaborators

  • SiV Consulting

    collaborator OTHER

  • Gainesville Eye Associates

    lead OTHER

Principal Investigators

  • Clayton G Blehm, MD · Gainesville Eye Associates

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-05
Primary Completion
2019-11-18
Completion
2019-11-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03856944 on ClinicalTrials.gov